# First American Financial Corp: financial statements, quarterly

FAF · NYSE · CIK 1472787 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/faf.md) · [Financials](/companies/faf/financials.md) · [Filings](/companies/faf/filings.md) · [Insiders](/companies/faf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/faf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,429 d](/filings/0001193125-26-055516.md) | [1,425](/filings/0000950170-25-058211.md) | [1,612](/filings/0000950170-25-098495.md) | [1,406](/filings/0001193125-25-248967.md) | [1,685 d](/filings/0001193125-26-055516.md) | [1,582](/filings/0001193125-26-174195.md) | [1,841](/filings/0001193125-26-314255.md) | [1,979](/filings/0001193125-26-429203.md) | [2,050 d](/filings/0001193125-26-055516.md) | [1,838](/filings/0001193125-26-174195.md) | [2,117](/filings/0001193125-26-314255.md) | [2,085](/filings/0001193125-26-429203.md) |
| Interest expense | $m | [33.3 d](/filings/0001193125-26-055516.md) | [34.3](/filings/0000950170-25-058211.md) | [35.4](/filings/0000950170-25-098495.md) | [36.2](/filings/0001193125-25-248967.md) | [43.7 d](/filings/0001193125-26-055516.md) | [35.2](/filings/0001193125-26-174195.md) | [38.0](/filings/0001193125-26-314255.md) | [39.9](/filings/0001193125-26-429203.md) | [43.9 d](/filings/0001193125-26-055516.md) | [41.9](/filings/0001193125-26-174195.md) | [45.7](/filings/0001193125-26-314255.md) | [46.4](/filings/0001193125-26-429203.md) |
| Income tax | $m | [4.1 d](/filings/0001193125-26-055516.md) | [11.6](/filings/0000950170-25-058211.md) | [35.2](/filings/0000950170-25-098495.md) | [(41.0)](/filings/0001193125-25-248967.md) | [27.0 d](/filings/0001193125-26-055516.md) | [21.8](/filings/0001193125-26-174195.md) | [48.1](/filings/0001193125-26-314255.md) | [57.1](/filings/0001193125-26-429203.md) | [74.0 d](/filings/0001193125-26-055516.md) | [37.0](/filings/0001193125-26-174195.md) | [64.8](/filings/0001193125-26-314255.md) | [51.0](/filings/0001193125-26-429203.md) |
| Net income | $m | [34.1 d](/filings/0001193125-26-055516.md) | [46.7](/filings/0000950170-25-058211.md) | [116](/filings/0000950170-25-098495.md) | [(104)](/filings/0001193125-25-248967.md) | [72.4 d](/filings/0001193125-26-055516.md) | [74.2](/filings/0001193125-26-174195.md) | [146](/filings/0001193125-26-314255.md) | [190](/filings/0001193125-26-429203.md) | [212 d](/filings/0001193125-26-055516.md) | [125](/filings/0001193125-26-174195.md) | [219](/filings/0001193125-26-314255.md) | [177](/filings/0001193125-26-429203.md) |
| Diluted EPS | $ per share | not reported | [0.45](/filings/0000950170-25-058211.md) | [1.11](/filings/0000950170-25-098495.md) | [(1.00)](/filings/0001193125-25-248967.md) | not reported | [0.71](/filings/0001193125-26-174195.md) | [1.41](/filings/0001193125-26-314255.md) | [1.84](/filings/0001193125-26-429203.md) | not reported | [1.21](/filings/0001193125-26-174195.md) | [2.12](/filings/0001193125-26-314255.md) | [1.72](/filings/0001193125-26-429203.md) |
| Basic EPS | $ per share | not reported | [0.45](/filings/0000950170-25-058211.md) | [1.11](/filings/0000950170-25-098495.md) | [(1.00)](/filings/0001193125-25-248967.md) | not reported | [0.72](/filings/0001193125-26-174195.md) | [1.41](/filings/0001193125-26-314255.md) | [1.84](/filings/0001193125-26-429203.md) | not reported | [1.21](/filings/0001193125-26-174195.md) | [2.13](/filings/0001193125-26-314255.md) | [1.72](/filings/0001193125-26-429203.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.6](/filings/0000950170-25-024488.md) | [1.5](/filings/0000950170-24-048522.md) | [2.0](/filings/0000950170-24-086667.md) | [3.0](/filings/0000950170-24-117138.md) | [1.7](/filings/0001193125-26-055516.md) | [2.0](/filings/0000950170-25-058211.md) | [2.0](/filings/0000950170-25-098495.md) | [2.9](/filings/0001193125-25-248967.md) | [1.4](/filings/0001193125-26-429203.md) | [2.4](/filings/0001193125-26-174195.md) | [2.6](/filings/0001193125-26-314255.md) | [1.7](/filings/0001193125-26-429203.md) |
| Total assets | $bn | [16.8](/filings/0001193125-26-055516.md) | [14.7](/filings/0000950170-25-058211.md) | [15.2](/filings/0000950170-25-098495.md) | [16.6](/filings/0001193125-25-248967.md) | [14.9](/filings/0001193125-26-055516.md) | [15.5](/filings/0001193125-26-174195.md) | [16.3](/filings/0000950170-25-098495.md) | [17.6](/filings/0001193125-25-248967.md) | [16.2](/filings/0001193125-26-429203.md) | [17.9](/filings/0001193125-26-174195.md) | [18.9](/filings/0001193125-26-314255.md) | [18.0](/filings/0001193125-26-429203.md) |
| Total liabilities | $bn | [11.9](/filings/0000950170-25-024488.md) | [9.9](/filings/0000950170-24-048522.md) | [10.3](/filings/0000950170-24-086667.md) | [11.5](/filings/0000950170-24-117138.md) | [10.0](/filings/0001193125-26-055516.md) | [10.5](/filings/0000950170-25-058211.md) | [11.1](/filings/0000950170-25-098495.md) | [12.3](/filings/0001193125-25-248967.md) | [10.7](/filings/0001193125-26-429203.md) | [12.4](/filings/0001193125-26-174195.md) | [13.3](/filings/0001193125-26-314255.md) | [12.6](/filings/0001193125-26-429203.md) |
| Shareholders' equity | $bn | [4.8](/filings/0000950170-25-024488.md) | [4.8](/filings/0000950170-24-048522.md) | [4.8](/filings/0000950170-24-086667.md) | [5.1](/filings/0000950170-24-117138.md) | [4.9](/filings/0001193125-26-055516.md) | [5.0](/filings/0000950170-25-058211.md) | [5.1](/filings/0000950170-25-098495.md) | [5.3](/filings/0001193125-25-248967.md) | [5.5](/filings/0001193125-26-429203.md) | [5.5](/filings/0001193125-26-174195.md) | [5.6](/filings/0001193125-26-314255.md) | [5.4](/filings/0001193125-26-429203.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(41.7) d](/filings/0001193125-26-055516.md) | [69.3](/filings/0000950170-25-058211.md) | [267 d](/filings/0000950170-25-098495.md) | [237 d](/filings/0001193125-25-248967.md) | [325 d](/filings/0001193125-26-055516.md) | [(52.8)](/filings/0001193125-26-174195.md) | [362 d](/filings/0001193125-26-314255.md) | [273 d](/filings/0001193125-26-429203.md) | [369 d](/filings/0001193125-26-055516.md) | [5.6](/filings/0001193125-26-174195.md) | [357 d](/filings/0001193125-26-314255.md) | [238 d](/filings/0001193125-26-429203.md) |
| Capital expenditure | $m | [58.1 d](/filings/0001193125-26-055516.md) | [51.7](/filings/0000950170-25-058211.md) | [56.7 d](/filings/0000950170-25-098495.md) | [51.5 d](/filings/0001193125-25-248967.md) | [58.4 d](/filings/0001193125-26-055516.md) | [41.7](/filings/0001193125-26-174195.md) | [52.4 d](/filings/0001193125-26-314255.md) | [49.4 d](/filings/0001193125-26-429203.md) | [44.8 d](/filings/0001193125-26-055516.md) | [38.3](/filings/0001193125-26-174195.md) | [39.2 d](/filings/0001193125-26-314255.md) | [41.4 d](/filings/0001193125-26-429203.md) |
| Dividends paid | $m | [54.5 d](/filings/0001193125-26-055516.md) | [54.9](/filings/0000950170-25-058211.md) | [54.7 d](/filings/0000950170-25-098495.md) | [55.6 d](/filings/0001193125-25-248967.md) | [55.5 d](/filings/0001193125-26-055516.md) | [55.7](/filings/0001193125-26-174195.md) | [55.3 d](/filings/0001193125-26-314255.md) | [56.0 d](/filings/0001193125-26-429203.md) | [56.0 d](/filings/0001193125-26-055516.md) | [56.2](/filings/0001193125-26-174195.md) | [56.1 d](/filings/0001193125-26-314255.md) | [0.0 d](/filings/0001193125-26-429203.md) |
| Share repurchases | $m | [17.7 d](/filings/0001193125-26-055516.md) | [3.5](/filings/0000950170-25-058211.md) | [40.7 d](/filings/0000950170-25-098495.md) | [16.1 d](/filings/0001193125-25-248967.md) | [8.2 d](/filings/0001193125-26-055516.md) | [28.2](/filings/0001193125-26-174195.md) | [60.5 d](/filings/0001193125-26-314255.md) | [33.6 d](/filings/0001193125-26-429203.md) | [0.0 d](/filings/0001193125-26-055516.md) | [33.5](/filings/0001193125-26-174195.md) | [20.5 d](/filings/0001193125-26-314255.md) | [1.5 d](/filings/0001193125-26-429203.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [105](/filings/0000950170-24-048522.md) | [105](/filings/0000950170-24-086667.md) | [104](/filings/0000950170-24-117138.md) | [104](/filings/0000950170-25-058211.md) | [104](/filings/0000950170-25-098495.md) | [104](/filings/0001193125-25-248967.md) | [104](/filings/0001193125-26-174195.md) | [104](/filings/0001193125-26-314255.md) | [103](/filings/0001193125-26-429203.md) | [103](/filings/0001193125-26-174195.md) | [103](/filings/0001193125-26-314255.md) | [103](/filings/0001193125-26-429203.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 102,100,000 at 2026-10-19, from the cover of the [10-Q filed 2026-10-23](/filings/0001193125-26-429203.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.